Clinical Trials Logo

Stage IIA Gastric Cancer clinical trials

View clinical trials related to Stage IIA Gastric Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01939275 Active, not recruiting - Clinical trials for Adenocarcinoma of the Gastroesophageal Junction

64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer

Start date: November 19, 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies copper Cu 64 (64Cu) tetra-azacyclododecanetetra-acetic acid (DOTA)-trastuzumab positron emission tomography (PET)/computed tomography (CT) in studying patients with gastric, or stomach cancer. Diagnostic procedures, such as copper Cu 64-DOTA-trastuzumab PET/CT, may help doctors study the characteristics of tumors and choose the best treatment.